China NMPA Product Recall - Baby warming station

GE Healthcare Systems Trading Development (Shanghai) Co., Ltd. initiated a voluntary Class II recall of certain infant warmers, as announced by the National Medical Products Administration (NMPA) on January 21, 2020. This action, also reported by the Shanghai Municipal Drug Administration (SFDA), addresses a significant safety concern. The primary issue identified is that when the infant warmer device is operated in manual mode without an attached temperature probe, the heating element continues to function at its user-set power level. Critically, this operation occurs without activating any alarm mechanisms or automatically reducing the heat output. This oversight presents a potential risk to patient safety, as excessive or uncontrolled heat could be delivered to an infant without proper notification or mitigation. The affected products are identified by Registration Certificate No.: CFDA (Imported) 2013 No. 3541372 and CFDA Import Registration No. 20163545180. The company’s proactive measure to voluntarily recall these devices aligns with medical device regulatory frameworks to ensure product safety and compliance. Detailed information regarding specific models, specifications, and batch numbers is available in the "Medical Device Recall Event Report Form" accompanying the NMPA's announcement, guiding healthcare providers and users on the necessary steps to address the recalled units. This recall underscores the importance of continuous product monitoring and prompt corrective actions to safeguard public health.